Skip to main content

Danaher Value Stock - Dividend - Research Selection

Danaher

ISIN: US2358511028 , WKN: 866197

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company\'s Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors. Its Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and flow cytometry products. The company offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians\' offices, reference laboratories, and other critical care settings. Its Dental segment provides consumables, equipment, and services to diagnose, treat, and prevent disease and ailments of the teeth, gums, and supporting bone. This segment offers implant systems, dental prosthetics, and associated treatment planning software; orthodontic bracket systems and lab products; endodontic systems and related consumables; restorative materials and instruments; infection prevention products; digital imaging systems and software; air and electric powered handpieces, and consumables; and treatment units. Its Environmental & Applied Solutions segment offers instrumentation, services, and disinfection systems to analyze, treat, and manage water in residential, commercial, industrial, and natural resource applications. This segment also provides equipment, software, services, and consumables for packaging, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Fleming Initiative and Cepheid Launch Landmark Study of Rapid Testing for Drug-Resistant Infections

2026-06-11
LONDON & SUNNYVALE, Calif., June 11, 2026--The Fleming Initiative, a partnership established by Imperial College London and Imperial College Healthcare NHS Trust to combat antimicrobial resistance (AMR), and Cepheid, a Danaher company, today announced the launch of TRACE-CPE, a two-and-a-half-year research study to improve testing for AMR, one of the greatest global health challenges.

Danaher Closes Acquisition of Masimo; Maintains Q2, 2026 Outlook

2026-06-10
Danaher (DHR) said Wednesday it has completed its acquisition of Masimo (MASI), a speciality diagnos

Danaher Completes Acquisition of Masimo Corporation

2026-06-10
Danaher Corporation (NYSE: DHR), a global science and technology innovator, announced today that it has completed the acquisition of Masimo Corporation, a leading specialty diagnostics provider of pulse oximetry and other patient monitoring solutions, primarily in acute care treatment settings.

Wolfe Research Downgrades Danaher Corporation (DHR)

2026-06-09
Danaher Corporation (NYSE:DHR) is one of the best healthcare stocks to buy with highest upside potential. Wolfe Research downgraded Danaher Corporation (NYSE:DHR) to Peer Perform from Outperform on June 1 without assigning a price target after assuming coverage of the name. It stated that growth forward and backward is similar, and Thermo Fisher is “a […]

Global Chromatography Market to Reach $21.50 Billion by 2031, Fueled by Biologic Purification Needs

2026-06-09
The global preparative and process chromatography market is anticipated to grow from USD 14.32 billion in 2026 to USD 21.50 billion by 2031, at a CAGR of 8.2%. This growth is driven by increased demand for vaccines, recombinant proteins, and personalized treatments, advancing chromatography as critical for biologics purification. The monoclonal antibodies & recombinant proteins segment dominates due to standardized purification workflows. Process chromatography products lead the market, supporte

Everpure Jumps 34% in a Year: Should Investors Bet on the Stock?

2026-06-09
P gains 33.9% in a year, powered by surging subscriptions, high ROE, and upbeat 2027-2028 revenue and EPS estimates.

SIRI Stock Surges 5% After-Hours On S&P MidCap 400 Inclusion

2026-06-08
The index provider said Sirius XM will take Masimo’s (MASI) slot in the benchmark effective prior to the market open on Thursday, June 11.

Sirius XM Holdings Set to Join S&P MidCap 400

2026-06-08
Sirius XM Holdings Inc. (NASD: SIRI) will replace Masimo Corp. (NASD: MASI) in the S&P MidCap 400 effective prior to the opening of trading on Thursday, June 11. S&P 500 & 100 constituent Danaher Corp. (NYSE: DHR) is acquiring Masimo in a deal expected to be completed soon pending final conditions.

Baron Discovery Fund Q1 2026: Who Moved The Needle

2026-06-08
Baron Discovery Fund declined 10.65% in Q1 2026, trailing its benchmark due to software headwinds. Read the full analysis for more details.

Why Wall Street Sees Danaher (DHR) Benefiting From Improving Industry Conditions

2026-06-07
With 110 hedge fund holders as of Q1 2026, Danaher Corporation (NYSE:DHR) is among the Top 10 Stocks That Members of Congress Own. On May 26, Citi resumed coverage of Danaher Corporation (NYSE:DHR) with a Buy rating and a $230 price target following a prior suspension of coverage. The firm pointed to Danaher’s reaffirmation of its fiscal […]